14-3-3 epsilon Antibody (4F8) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-59395G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Immunocytochemistry/ Immunofluorescence, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 4F8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant human 14-3-3 epsilon (1-255aa) purified from E. coli
Reactivity Notes
0
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for 14-3-3 epsilon Antibody (4F8) [DyLight 488]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: 14-3-3 epsilon
Alternate Names
1433 epsilon, YWHAE
Gene Symbol
YWHAE
Additional 14-3-3 epsilon Products
Product Documents for 14-3-3 epsilon Antibody (4F8) [DyLight 488]
Product Specific Notices for 14-3-3 epsilon Antibody (4F8) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...